biote Corp
For the period ended Dec 31, 2023. Filed Mar 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures Power of Attorney (included on signature page)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| BIOTE CORP. | ||
| Date: March 15, 2024 | By: | /s/ Teresa S. Weber |
|---|---|---|
| Name: Teresa S Weber | ||
| Title: Chief Executive Officer and Director (Principal Executive Officer) | ||
| Date: March 15, 2024 | By: | /s/ Robert C. Peterson |
| Name: Robert C. Peterson | ||
| Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | ||
POWER OF ATTORNEY
Each person whose individual signature appears below hereby authorizes and appoints Teresa S. Weber and Robert C. Peterson, and each of them, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
| Name | Position | Date |
|---|---|---|
| /s/ Teresa S. WeberTeresa S. Weber | Chief Executive Officer and Director(Principal Executive Officer) | March 15, 2024 |
| /s/ Robert C. PetersonRobert C. Peterson | Chief Financial Officer(Principal Financial Officer and Principal Accounting Officer) | March 15, 2024 |
| /s/ Marc D. BeerMarc D. Beer | Executive Chairman andChairman of the Board | March 15, 2024 |
| /s/ Dana JacobyDana Jacoby | Director | March 15, 2024 |
| /s/ Mark ConeMark Cone | Director | March 15, 2024 |
| /s/ Steven J. HeyerSteven J. Heyer | Director | March 15, 2024 |
| /s/ Andrew R. HeyerAndrew R. Heyer | Director | March 15, 2024 |
| /s/ Debra L. MorrisDebra L. Morris | Director | March 15, 2024 |
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34) | F-2 |
|---|---|
| Consolidated Balance Sheets | F-3 |
| Consolidated Statements of Income (Loss) And Comprehensive Income (Loss) | F-4 |
| Consolidated Statements of Stockholders’ Equity (Deficit) | F-5 |
| Consolidated Statements of Cash Flows | F-7 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.